Novartis Foundation Symposium 234 - Chronic Obstructive Pulmonary Disease - Pathogenesis to Treatment (Hardcover, 234)

Chronic obstructive pulmonary disease (COPD) is the most common respiratory disorder of adults in the developed world and is the fourth main cause of death in the USA. It is also associated with high morbidity, and poses an enormous burden of suffering and expense. Despite this, the disease has received little attention compared with other respiratory conditions such as asthma and lung cancer.
Current treatment can offer some marginal symptomatic relief but does not address the underlying disease process. Indeed, smoking cessation is the only intervention known to alter the rate of disease progression. There is clearly great need, and potential, for the development of superior therapies for symptomatic relief and disease modification. This book brings together leading researchers and physicians to discuss the most recent advances in our understanding of COPD, and draws together basic and clinical aspects relevant to the topic. Coverage includes the basic pathology, current and potential therapies, and detailed consideration of the major theories for the pathogenesis of COPD.

General

Imprint:	John Wiley & Sons
Country of origin:	United States
Release date:	November 2000
First published:	2001
Authors:	Novartis
Dimensions:	232 x 157 x 20mm (L x W x T)
Format:	Hardcover
Pages:	296
Edition:	234
ISBN-13:	978-0-471-49437-9
Categories:	Books > Medicine > Clinical & internal medicine > Respiratory medicine Books > Science & Mathematics > Biology, life sciences > Molecular biology Books > Medicine > Pre-clinical medicine: basic sciences > Physiology > Cellular physiology
LSN:	0-471-49437-2
Barcode:	9780471494379

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!